65 results
8-K
EX-1.1
URGN
UroGen Pharma Ltd
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
and payable, any related or similar assessment, fine or penalty levied against any of them except, in each case, (i) as may be being contested in good
8-K
EX-99.1
URGN
UroGen Pharma Ltd
13 Jun 24
Regulation FD Disclosure
10:51am
Assessment) Follow -up Period Cystoscopy, for cause biopsy, and urine cytology every 3 months for up to 24 Progression to months and every 6 months thereafter
8-K
EX-99.1
zk8c9hd
4 Mar 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
669jx8 ygmyg
7 Feb 24
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
9aqf kprjtdr
14 Nov 23
UroGen Pharma Reports Third Quarter 2023 Financial Results
12:00am
8-K
EX-99.1
592hmx9bk6x4alu7rotw
10 Aug 23
UroGen Pharma Reports Record JELMYTO Quarterly Sales and Recent Corporate Developments
8:01am
8-K
EX-99.3
4ir8js9
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am
8-K
EX-10.1
9krck3ew
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am
8-K
EX-99.2
ydxaggc1
27 Jul 23
UroGen Announces $120 Million Private Placement of Ordinary Shares
9:57am
8-K
EX-99.1
emylr lr73o505
11 May 23
UroGen Pharma Meets Revenue Goal, Reports First Quarter 2023 Financial Results and Recent Corporate Developments
8:05am